Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| RO2-M52H3 | Mouse | Mouse ROR2 / NTRKR2 Protein, His Tag (MALS verified) |  |
|
|
| RO2-H82E3 | Human | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ |  |
|
|
| RO2-M5253 | Mouse | Mouse ROR2 / NTRKR2 Protein, Fc Tag |  |
|
|
| RO2-H52E5 | Human | Human ROR2 / NTRKR2 Protein, His Tag |  |
|
|
| RO2-H5251 | Human | Human ROR2 / NTRKR2 Protein, Fc Tag |  |
|
Immobilized Human ROR2, His Tag (Cat. No. RO2-H52E5) at 1 μg/mL (100 μL/well) can bind Anti-ROR2 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Mouse ROR2 Protein, His Tag (Cat. No. RO2-M52H3) is more than 85% and the molecular weight of this protein is around 45-65 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
| Ozuriftamab Vedotin | CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
| Ozuriftamab Vedotin | CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.
A-Z
